NAV on (13 Oct 2026 )
₹16.89 ▼
(-0.48%)
Fund Size
₹926.55 Crores
1Y Returns
16.81 %
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.
WhiteOak Capital Asset Management Ltd.
Launch Date
January 16, 2024
Fund Manager
Mr. Ramesh Mantri
Initial Price
10
AUM Fund
926.55 Cr
Min investment
Rs 500
Expense Ratio
1.13%
Daily - Rs. 100/- and in multiple of Re. 1/- thereafter. Minimum installments 6.Weekly - Rs. 100/- and in multiple of Re. 1/- thereafter. Minimum installments 6.Fortnightly - Rs. 100/- and in multiple of Re. 1/- thereafter. Minimum installments 6.Monthly - Rs. 100/- and in multiple of Re. 1/- thereafter. Minimum installments 6.Quarterly -Rs. 500/- and in multiple of Re. 1/- thereafter. Minimum installments 4.
Nil
1 Month
-4.85%
6 Months
+19.29%
1 Year
+16.81%
2 Years (CAGR)
+12.48%
3 Years (CAGR)
NA
5 Years (CAGR)
NA
| Equity / Mid Cap funds | 1Y | 3Y | Fund Size (Cr) |
|---|---|---|---|
| 22.47% | 0.00% | ₹825.14 | |
| 22.47% | 0.00% | ₹825.14 | |
| 21.60% | 114.02% | ₹3310.64 | |
| 21.60% | 114.02% | ₹3310.64 | |
| 20.56% | 0.00% | ₹825.14 |
Q: What is the current NAV of WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth?
A: The latest NAV of WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth is ₹ 16.89 as on 13 Oct 2026.
Q: What type of mutual fund is WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth?
A: WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth is a 'Equity - Pharma' type mutual fund managed by 'WhiteOak Capital Asset Management Ltd.'.
Q: What is the expense ratio of WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth?
A: The expense ratio of WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth is 1.13%, which impacts overall returns.
Q: Who manages WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth?
A: WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth is managed by Mr. Ramesh Mantri, who oversees investment strategy and portfolio decisions.
Q: Is WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth a good investment?
A: WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth may be suitable depending on your financial goals, risk appetite, and investment horizon. Always evaluate fund performance and consult a financial advisor.
Q: What is the exit load of WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth?
A: The exit load of WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth is Nil, applicable if redeemed within the specified period.
Q: How is WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth taxed?
A: Taxation depends on the fund type (equity/debt) and holding period as per Indian tax laws.
